CompaniesMediLumine
MediLumine logo

MediLumine

active
Montréal, QC, Canada
Founded 2013
Website
About

Imaging Agents, Receptor Modulators for research, formulation services

Areas of Focus

Categories

Non-PharmaceuticalContract Research
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

200

By Phase

PHASE1: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
NCT06898957
Hover over trial bars to see details

Recent Trials

NCT06898957Collaborator
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
PHASE1Recruiting
200 participants
Started: May 16, 2025 · Completed: Apr 23, 2031
Locations (1)
Headquarters
Montréal, QC, Canada
Map

Loading map...